BETA-LACTAMASE-HEMMER
Patent europeic · EP3882252 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3882252
- Numer da la dumonda
- EP21157549
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 11-06-2015
- Publitgà
- 22-09-2021
- Concedì
- 19-11-2025
- La protecziun finescha il pli tard
- 10-06-2035
- Proxima taxa annuala scadenta
- 30-06-2026
- Classas IPC
- C07F 5/02 (2006.01)A61K 31/69 (2006.01)A61K 31/43 (2006.01)A61P 31/00 (2006.01)
- Prioritad
- US 201462010969 P 11.06.2014US 201462010940 P 11.06.2014US 201462010968 P 11.06.2014US 201562118227 P 19.02.2015
- Derivà da
- EP15806746
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 30-09-2026
Midada
Published in Swissreg on 30.09.2026
- 16-04-2026
Owner
- Owner
- Venatorx Pharmaceuticals, Inc., 30 Spring Mill Drive, Malvern, PA 19355, USA → Basilea Pharmaceutica International AG, Allschwil, Hegenheimermattweg 167b, 4123 Allschwil
Published in Swissreg on 16.04.2026
- 19-11-2025
Concedì
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.11.2025
Partidas
Inventur
Malvern, Pennsylvania 19355, US
Maryland 21154, US
Dayton, New Jersey 08810, US
Livingston, Montana 59047, US
New Holland, Pennsylvania 17557, US
Malvern, Pennsylvania 19355, US
Downingtown, Pennsylvania 19335, US
Collegeville, Pennsylvania 19426, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.